|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
84,540,000 |
Market
Cap: |
346.61(M) |
Last
Volume: |
34,905,322 |
Avg
Vol: |
12,541,775 |
52
Week Range: |
$4.1 - $4.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Olson William C |
VP, Research & Development |
|
2009-04-01 |
4 |
OE |
$5.65 |
$11,379 |
D/D |
2,014 |
38,177 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2009-04-01 |
4 |
D |
$6.65 |
$12,183 |
D/D |
(1,832) |
36,163 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2009-04-01 |
4 |
OE |
$5.65 |
$11,978 |
D/D |
2,120 |
38,699 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2009-04-01 |
4 |
D |
$6.65 |
$12,828 |
D/D |
(1,929) |
36,579 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2009-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
66,294 |
786,442 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2009-01-02 |
4 |
D |
$10.74 |
$12,577 |
D/D |
(1,171) |
37,827 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2009-01-02 |
4 |
OE |
$9.13 |
$11,750 |
D/D |
1,287 |
38,998 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2009-01-02 |
4 |
D |
$10.74 |
$13,242 |
D/D |
(1,233) |
39,231 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2009-01-02 |
4 |
OE |
$9.13 |
$12,371 |
D/D |
1,355 |
40,464 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2009-01-02 |
4 |
D |
$10.74 |
$17,764 |
D/D |
(1,654) |
41,360 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2009-01-02 |
4 |
OE |
$9.13 |
$16,607 |
D/D |
1,819 |
43,014 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2009-01-02 |
4 |
D |
$10.74 |
$19,858 |
D/D |
(1,849) |
27,487 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2009-01-02 |
4 |
OE |
$9.13 |
$18,561 |
D/D |
2,033 |
29,336 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2009-01-02 |
4 |
D |
$10.74 |
$13,242 |
D/D |
(1,233) |
38,340 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2009-01-02 |
4 |
OE |
$9.13 |
$12,371 |
D/D |
1,355 |
39,573 |
|
- |
|
Jacobson Paul F |
Director |
|
2008-10-23 |
4 |
S |
$9.05 |
$244,458 |
D/D |
(27,000) |
125,600 |
|
- |
|
Jacobson Paul F |
Director |
|
2008-10-22 |
4 |
S |
$9.39 |
$333,168 |
D/D |
(35,500) |
152,600 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2008-10-01 |
4 |
D |
$13.93 |
$14,083 |
D/D |
(1,011) |
37,604 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2008-10-01 |
4 |
OE |
$6.53 |
$9,691 |
D/D |
1,484 |
38,615 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2008-10-01 |
4 |
D |
$13.93 |
$22,720 |
D/D |
(1,631) |
27,196 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2008-10-01 |
4 |
OE |
$6.53 |
$15,626 |
D/D |
2,393 |
28,827 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2008-10-01 |
4 |
D |
$13.93 |
$41,609 |
D/D |
(2,987) |
38,111 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2008-10-01 |
4 |
OE |
$6.53 |
$28,628 |
D/D |
4,384 |
41,098 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2008-10-01 |
4 |
D |
$13.93 |
$23,166 |
D/D |
(1,663) |
41,088 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2008-10-01 |
4 |
OE |
$6.53 |
$15,940 |
D/D |
2,441 |
42,751 |
|
- |
|
801 Records found
|
|
Page 10 of 33 |
|
|